In our sample, the MDD+MCI group has a greater proportion of APOE4 carriers compared to the MDD group (41.7% versus 14.3%, respectively), however, our small sample size precludes any analysis of the relationship between APOE4 status, depression, WMH, and AD. The gene discussed is APOE; the disease is depressive symptom measurement.